147 related articles for article (PubMed ID: 32122680)
21. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
22. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
[TBL] [Abstract][Full Text] [Related]
23. Severity of white matter hyperintensities in older adults aged in their mid 80s and its relationship with hemodynamic and cardiac parameters.
Todoroki K; Ikeya Y; Fukui S; Yanagimachi N; Okazaki T; Tanaka C; Tanaka E; Shizuma T; Fukuyama N; Mori H
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():66-73. PubMed ID: 26671160
[TBL] [Abstract][Full Text] [Related]
24. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
[TBL] [Abstract][Full Text] [Related]
25. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
26. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
[TBL] [Abstract][Full Text] [Related]
27. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
28. Impact of night-time blood pressure on cerebral white matter hyperintensity in elderly hypertensive patients.
Kokubo M; Shimizu A; Mitsui T; Miyagi M; Nomoto K; Murohara T; Toba K; Sakurai T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():59-65. PubMed ID: 26671159
[TBL] [Abstract][Full Text] [Related]
29. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
[TBL] [Abstract][Full Text] [Related]
30. The effect of white matter hyperintensities on regional brain volumes and white matter microstructure, a population-based study in HUNT.
Vangberg TR; Eikenes L; Håberg AK
Neuroimage; 2019 Dec; 203():116158. PubMed ID: 31493533
[TBL] [Abstract][Full Text] [Related]
31. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
[TBL] [Abstract][Full Text] [Related]
32. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints.
Kearney-Schwartz A; Rossignol P; Bracard S; Felblinger J; Fay R; Boivin JM; Lecompte T; Lacolley P; Benetos A; Zannad F
Stroke; 2009 Apr; 40(4):1229-36. PubMed ID: 19246701
[TBL] [Abstract][Full Text] [Related]
33. Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.
Lin Q; Huang WQ; Tzeng CM
Rev Neurosci; 2015; 26(3):343-58. PubMed ID: 25781674
[TBL] [Abstract][Full Text] [Related]
34. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
[TBL] [Abstract][Full Text] [Related]
35. [Cognitive impairment associated to leukoaraiosis: its pathophysiology, clinical manifestations and treatment].
Jiménez I; Agulla J; Pouso M; Sabucedo M; Rodríguez-Yáñez M; Sobrino T; Brea D; Blanco M; Leira R; Castillo J
Rev Neurol; 2008 Nov 16-30; 47(10):536-44. PubMed ID: 19012258
[TBL] [Abstract][Full Text] [Related]
36. Brain white matter damage in aging and cognitive ability in youth and older age.
Valdés Hernández Mdel C; Booth T; Murray C; Gow AJ; Penke L; Morris Z; Maniega SM; Royle NA; Aribisala BS; Bastin ME; Starr JM; Deary IJ; Wardlaw JM
Neurobiol Aging; 2013 Dec; 34(12):2740-7. PubMed ID: 23850341
[TBL] [Abstract][Full Text] [Related]
37. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
[TBL] [Abstract][Full Text] [Related]
38. White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.
Watson C; Busovaca E; Foley JM; Allen IE; Schwarz CG; Jahanshad N; Nir TM; Esmaeili-Firidouni P; Milanini B; Rosen H; Carmichael OT; Thompson PM; Valcour VG
J Neurovirol; 2017 Jun; 23(3):422-429. PubMed ID: 28101804
[TBL] [Abstract][Full Text] [Related]
39. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
[TBL] [Abstract][Full Text] [Related]
40. Functional health and white matter hyperintensities as effect modifiers of blood pressure-lowering on cognitive function and vascular events in older Secondary Prevention of Small Subcortical Strokes trial participants.
Blum MR; Scherzer R; Ikeme JC; Benavente OR; McClure LA; Peralta CA; Odden MC
J Hypertens; 2020 Aug; 38(8):1578-1585. PubMed ID: 32371759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
